Limited Transgene Immune Response and Long-Term Expression of Human α-L-Iduronidase in Young Adult Mice with Mucopolysaccharidosis Type I by Liver …

C Di Domenico, D Di Napoli, E Gonzalez Y Reyero, A Lombardo, Luigi Naldini, P Di Natale
2006-11-01
Abstract:Mucopolysaccharidosis type I (MPS I) due to deficient α-L-iduronidase (IDUA) activity results in the accumulation of glycosaminoglycans (GAGs) in many of the cells of affected patients. Stable gene replacement by in vivo administration of lentiviral vectors (LVs) has therapeutic potential for metabolic disorders and other systemic diseases. We have previously shown in a murine model the therapeutic potential of lentiviral IDUA vector-mediated gene therapy, in which human IDUA cDNA was driven by the cytomegalovirus promoter. However, the major limitation of this approach was the induction of an immune response against the therapeutic protein, which limited the efficacy and long-term duration of treatment. In this study, we evaluate the potential of liver-directed gene therapy, that is, programming of murine hepatocytes to secrete the enzyme with mannose 6-phosphate (M6P), which can be taken up by distant …
What problem does this paper attempt to address?